Novo Nordisk Overview
Novo Nordisk Target Price
See Novo Nordisk's analyst price targets ($47) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$46.6
Average Target Price
$47.00
0.9% upside
0.9% upside2 analysts in the last 4 months
High: $47 | Low: $47
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-12 | Berenberg BankKerry Holford | $47 | 0.9% upside |  |
| 2026-08-06 | BMO CapitalEvan Seigerman | $47 | 0.9% upside | |
| 2026-02-05 | BMO Capital | $45 |  3.4% downside | |
| 2026-01-26 | BMO CapitalEvan Seigerman | $57 | 22.3% upside | |
| 2025-12-10 | HSBC | $54 | 15.9% upside | |
| 2025-12-03 | Morgan StanleyThibault Boutherin | $42 | 9.9% downside | |
| 2025-11-25 | BMO CapitalEvan Seigerman | $46 | 1.3% downside | |
| 2025-10-14 | BMO CapitalEvan Seigerman | $55 | 18% upside | |
| 2025-10-01 | HSBC | $70 | 50.2% upside | |
| 2025-09-29 | Morgan Stanley | $47 | 0.9% upside | |
| 2025-07-31 | HSBC | $57 | 22.3% upside | |
| 2025-07-23 | Truist FinancialJailendra Singh | $48 | 3% upside | |
| 2024-10-17 | BMO CapitalEvan Seigerman | $156 | 234.8% upside | |
| 2024-09-11 | Cantor FitzgeraldLouise Chen | $160 | 243.3% upside | |
| 2024-08-08 | BMO CapitalEvan David Seigerman | $160 | 243.3% upside | |
| 2024-06-10 | Argus ResearchJasper Hellweg | $160 | 243.3% upside | |
| 2024-05-30 | Goldman SachsJames Quigley | $156 | 234.8% upside | |
| 2024-04-12 | BMO CapitalEvan David Seigerman | $163 | 249.8% upside | |